Atebimetinib with modified chemo led to 94% 6-month survival rates in first-line pancreatic cancer, with durable responses ...

The bad news is you have ductal carcinoma in situ. The good news is that DCIS is the best type of breast cancer to get.

A study explores how prior authorization requirements; coverage stoppages and other red tape can generate barriers to life ...

I was diagnosed with follicular lymphoma in 2020, during COVID, which forced me to retire early and taught me I’m more than a ...

For patients with metastatic HR+/HER2— breast cancer, there were various trials to have come out of ASCO 2025 that are worth keeping your eye on.

Dr. Sara M. Tolaney breaks down key takeaways from the DESTINY-Breast09 trial that patients with HER2+ advanced or metastatic ...

Both non-small lung cancer and small cell lung cancer is a disease that now has various therapeutic options available, ...

Breyanzi demonstrated a 95.5% response rate among patients with relapsed/refractory marginal zone lymphoma, as well as a ...

I feel unprepared and overwhelmed after my breast cancer diagnosis, facing treatment like a race, hoping for the strength to ...

I became a colon cancer survivor after my 2020 diagnosis, and I share how my scars, mindset shifts and journaling helped me ...

ASCO Annual Meeting highlighted key advances in brain cancer and brain metastases for patients affected by the disease.

If there is ever an annual follow up CT scan that does not cause me significant anxiety, this year will be the one.